Publication | Open Access

Maintenance Therapy with 3-monthly Bacillus Calmette-Guérin for 3 Years is Not Superior to Standard Induction Therapy in High-risk Non–muscle-invasive Urothelial Bladder Carcinoma: Final Results of Randomised CUETO Study 98013

Urological ResearchSurgical OncologyUrologyUrologic Cancer EpidemiologyGenitourinary CancerMedicineMaintenance Therapy3-Monthly Bacillus Calmette-guérinStandard Induction TherapyOncologyCancer Research